789 related articles for article (PubMed ID: 17548499)
1. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Yamane K; Wachino J; Suzuki S; Kimura K; Shibata N; Kato H; Shibayama K; Konda T; Arakawa Y
Antimicrob Agents Chemother; 2007 Sep; 51(9):3354-60. PubMed ID: 17548499
[TBL] [Abstract][Full Text] [Related]
2. A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China.
Xia LN; Li L; Wu CM; Liu YQ; Tao XQ; Dai L; Qi YH; Lu LM; Shen JZ
Foodborne Pathog Dis; 2010 Feb; 7(2):207-15. PubMed ID: 19911944
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of plasmid-mediated fluoroquinolone resistance genes, qepA and qnrS1, in Enterobacter aerogenes co-producing RmtB and class A beta-lactamase LAP-1.
Park YJ; Yu JK; Kim SI; Lee K; Arakawa Y
Ann Clin Lab Sci; 2009; 39(1):55-9. PubMed ID: 19201742
[TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of plasmid-mediated quinolone resistance determinants in chicken Escherichia coli isolates from 2001 to 2007.
Huang SY; Dai L; Xia LN; Du XD; Qi YH; Liu HB; Wu CM; Shen JZ
Foodborne Pathog Dis; 2009 Dec; 6(10):1203-9. PubMed ID: 19735206
[TBL] [Abstract][Full Text] [Related]
5. Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Périchon B; Courvalin P; Galimand M
Antimicrob Agents Chemother; 2007 Jul; 51(7):2464-9. PubMed ID: 17470656
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of resistance and mobility among multidrug-resistant CTX-M-producing Escherichia coli from Canadian intensive care units: the 1st report of QepA in North America.
Baudry PJ; Nichol K; DeCorby M; Lagacé-Wiens P; Olivier E; Boyd D; Mulvey MR; Hoban DJ; Zhanel GG
Diagn Microbiol Infect Dis; 2009 Mar; 63(3):319-26. PubMed ID: 19216943
[TBL] [Abstract][Full Text] [Related]
7. Plasmid-mediated quinolone resistance determinants among enterobacterial isolates from outpatients in Brazil.
Minarini LA; Poirel L; Cattoir V; Darini AL; Nordmann P
J Antimicrob Chemother; 2008 Sep; 62(3):474-8. PubMed ID: 18552340
[TBL] [Abstract][Full Text] [Related]
8. Plasmid-mediated fluoroquinolone efflux pump gene, qepA, in Escherichia coli clinical isolates in Korea.
Kim ES; Jeong JY; Choi SH; Lee SO; Kim SH; Kim MN; Woo JH; Kim YS
Diagn Microbiol Infect Dis; 2009 Nov; 65(3):335-8. PubMed ID: 19717263
[TBL] [Abstract][Full Text] [Related]
9. Dissemination of IncFII plasmids carrying rmtB and qepA in Escherichia coli from pigs, farm workers and the environment.
Deng Y; Zeng Z; Chen S; He L; Liu Y; Wu C; Chen Z; Yao Q; Hou J; Yang T; Liu JH
Clin Microbiol Infect; 2011 Nov; 17(11):1740-5. PubMed ID: 21375663
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
Chenia HY; Pillay B; Pillay D
J Antimicrob Chemother; 2006 Dec; 58(6):1274-8. PubMed ID: 17040923
[TBL] [Abstract][Full Text] [Related]
11. qnr, aac(6')-Ib-cr and qepA genes in Escherichia coli and Klebsiella spp.: genetic environments and plasmid and chromosomal location.
Ruiz E; Sáenz Y; Zarazaga M; Rocha-Gracia R; Martínez-Martínez L; Arlet G; Torres C
J Antimicrob Chemother; 2012 Apr; 67(4):886-97. PubMed ID: 22223228
[TBL] [Abstract][Full Text] [Related]
12. Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
Ode T; Saito R; Kumita W; Sato K; Okugawa S; Moriya K; Koike K; Okamura N
Int J Antimicrob Agents; 2009 Oct; 34(4):347-50. PubMed ID: 19560903
[TBL] [Abstract][Full Text] [Related]
13. Characterization of clinical Escherichia coli isolates from China containing transferable quinolone resistance determinants.
Yang J; Luo Y; Li J; Ma Y; Hu C; Jin S; Ye L; Cui S
J Antimicrob Chemother; 2010 Mar; 65(3):453-9. PubMed ID: 20056688
[TBL] [Abstract][Full Text] [Related]
14. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.
Mammeri H; Van De Loo M; Poirel L; Martinez-Martinez L; Nordmann P
Antimicrob Agents Chemother; 2005 Jan; 49(1):71-6. PubMed ID: 15616277
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs.
Gibson JS; Cobbold RN; Kyaw-Tanner MT; Heisig P; Trott DJ
Vet Microbiol; 2010 Nov; 146(1-2):161-6. PubMed ID: 20471187
[TBL] [Abstract][Full Text] [Related]
16. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
[TBL] [Abstract][Full Text] [Related]
18. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of fluoroquinolones and fluoroquinolone-resistance genes in the aquatic environment.
Adachi F; Yamamoto A; Takakura K; Kawahara R
Sci Total Environ; 2013 Feb; 444():508-14. PubMed ID: 23291652
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolates in Wenzhou, Southern China, 2002-2008.
Zhou TL; Chen XJ; Zhou MM; Zhao YJ; Luo XH; Bao QY
Jpn J Infect Dis; 2011; 64(1):55-7. PubMed ID: 21266756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
